Fludarabine is a comparatively new drug for the treatment of low-grade lymphoid malignancy. This report describes five cases of unusual
neurological illnesses occurring after treatment with fludarabine. These suggest that caution should be exercised in patients receiving
fludarabine who develop neurological abnormalities, with prompt investigation and if necessary cessation of the drug.
